Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
FundaMental Pharma logo — Overcoming Barriers in Treatment-Resistant Depression

FundaMental Pharma

Overcoming Barriers in Treatment-Resistant Depression

Founded 2016 Germany Heidelberg, Germany 11 employees Seed Total: $12.70M

General Information

Company Name FundaMental Pharma
Founded Year 2016
Location Germany Heidelberg, Germany +1
Employees 11
Funding Stage Seed
Social

Get notified when FundaMental Pharma moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About FundaMental Pharma

FundaMental Pharma is an early stage start-up company founded in 2016, headquartered in Germany, operating in the Health Care industry. The company's slogan, "We Fight Neurodegeneration," captures its commitment to pioneering the development of neuroprotective small molecules with a novel pharmacological mode of action. These molecules, known as FMP neuroprotectiva, show promise in addressing a wide array of currently untreatable human neurological conditions, including vascular brain damage, dementia, traumatic brain injury, amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD), Huntington's disease (HD), retina degeneration, and brain damage caused by virus or parasite infections. Attracted the attention of the venture capital community with its recent €2.70MSeed Round investment on 11 April 2024, with the backing of the Novartis Venture Fund. The injection of funds from a prominent investor like the Novartis Venture Fund signifies a strong vote of confidence in FundaMental Pharma's innovative approach and potential to make a significant impact in the field of neurodegenerative disease treatment. In summary, FundaMental Pharma's groundbreaking research and development in the neuroprotective space, coupled with its recent successful funding round led by Novartis Venture Fund, position the company as a compelling player to watch in the dynamic landscape of neurodegenerative disease therapeutics.

Taxonomy: Neurodegeneration, Neuroprotective, Small Molecules, Pharmacological Mode of Action, Vascular Brain Damage, Dementia, Traumatic Brain Injury, Amyotrophic Lateral Sclerosis, Alzheimer’s Disease, Huntington’s Disease, Retina Degeneration, Preclinical Stage, Neuroscience, Drug Development

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed •••••• 1
Investor
01 Apr 2024
Seed •••••• 4
Investor Investor Investor Investor
01 Nov 2022
Spinout •••••• 1 •••• •••• 01 Sep 2016

FundaMental Pharma Alternatives & Competitors

FundaMental Pharma vs
BrainCells
BrainCells

Pioneering biopharmaceutical solutions to enhance neuron growth and address CNS disorders with advan...

Debt Financing
Biotechnology, Health Care
FundaMental Pharma vs
Relmada Therapeutics, Inc
Relmada Therapeutics, Inc United States

Relmada (Nasdaq: $RLMD) is a clinical-stage company developing novel therapies for the treatment of...

Post Ipo Equity
32 employees
Biotechnology, Pharmaceutical
FundaMental Pharma vs
Redemption Psychiatry
Redemption Psychiatry United States

Mission: To provide the highest quality psychiatric care using the most advanced, evidence-based tr...

74 employees
Health Care
Also compare with: FundaMental Pharma vs Amolyt Pharma Amolyt Pharma

FAQ About FundaMental Pharma

Overcoming Barriers in Treatment-Resistant Depression
FundaMental Pharma was founded in 2016.
FundaMental Pharma is headquartered in Heidelberg, Germany.
FundaMental Pharma has approximately 11 employees.
FundaMental Pharma has completed 3 funding rounds, raising a total of $12.70M. The latest funding stage is Seed.
Top alternatives and competitors to FundaMental Pharma include BrainCells, Relmada Therapeutics, Inc, Redemption Psychiatry, Lys Therapeutics, Amolyt Pharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
FundaMental Pharma and BrainCells are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors FundaMental Pharma and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes